CD47 and cancer: Immune surveillance escape occurred by hijacking the corresponding inhibitory pathways via overexpressed checkpoint genes such as PD-L1 and CD47; thus, phagocytosis checkpoints have emerged as essential checkpoints for cancer immunotherapy (87).